Released Jun 14, 2012, after the close
10-Q filed Jun 14, 2012, 45 days after period end · 0001354488-12-003234
Q2 2012 · 10-Q
Revenue—
Net Income$1.19M$1.19M +147.7% vs Q2 2011+3.6% vs Q1 2012
EPS Diluted$0.05$0.05 +147.6% vs Q2 2011+4.0% vs Q1 2012
Gross Profit$2,396,143+55.1%
Operating Income$1,425,813+93.5%
Operating Cash Flow-$99,711N/M
Free Cash Flowderived-$188,589N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Net Income | $1.19M | $479.69K |
| EPS Diluted | $0.05 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR